Stay updated with breaking news from Evaa Mistry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preliminary results of a new study showed that using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg in these patients may not be beneficial, and may even be harmful.
The largest study to date to look at this issue has actually found a lower rate of symptomatic intracerebral hemorrhage in patients on DOACs receiving thrombolysis than those not taking anticoagulants.
Research Highlights: In an international, retrospective analysis of direct oral anti-clotting medications that target a single clotting factor worked